当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Risankizumab
DRUG FOR FURTHER PROCESSING
0074-9010
AbbVie Inc.
20221117
RISANKIZUMAB
DRUG FOR FURTHER PROCESSING
360
0074-9010_928a30aa-9185-43e2-a4b3-877a8b5b2bd7
Risankizumab
DRUG FOR FURTHER PROCESSING
0074-9011
AbbVie Inc.
20250204
RISANKIZUMAB
DRUG FOR FURTHER PROCESSING
360
0074-9011_238cd8ba-a442-4f27-a44f-448dd3d5e827
amlodipine besylate and valsartan
HUMAN PRESCRIPTION DRUG
0078-1266
Novartis Pharmaceuticals Corporation
20070620
AMLODIPINE BESYLATE; VALSARTAN
DRUG FOR FURTHER PROCESSING
5; 160
0078-1266_8d2b2e7f-6f52-4f0f-a734-609ab9cf74d0
amlodipine valsartan and hydrochlorothiazide
HUMAN PRESCRIPTION DRUG
0078-1273
Novartis Pharmaceuticals Corporation
20090404
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTA
DRUG FOR FURTHER PROCESSING
5; 12.5; 160
0078-1273_a2f8e96b-1cbc-4d5a-b61d-af5b990f1ece
amlodipine valsartan and hydrochlorothiazide
HUMAN PRESCRIPTION DRUG
0078-1280
Novartis Pharmaceuticals Corporation
20090404
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTA
DRUG FOR FURTHER PROCESSING
10; 25; 320
0078-1280_a2f8e96b-1cbc-4d5a-b61d-af5b990f1ece
amlodipine valsartan and hydrochlorothiazide
HUMAN PRESCRIPTION DRUG
0078-1287
Novartis Pharmaceuticals Corporation
20090404
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTA
DRUG FOR FURTHER PROCESSING
5; 25; 160
0078-1287_a2f8e96b-1cbc-4d5a-b61d-af5b990f1ece
amlodipine valsartan and hydrochlorothiazide
HUMAN PRESCRIPTION DRUG
0078-1294
Novartis Pharmaceuticals Corporation
20090404
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTA
DRUG FOR FURTHER PROCESSING
10; 25; 160
0078-1294_a2f8e96b-1cbc-4d5a-b61d-af5b990f1ece
amlodipine besylate and valsartan
HUMAN PRESCRIPTION DRUG
0078-1301
Novartis Pharmaceuticals Corporation
20070620
AMLODIPINE BESYLATE; VALSARTAN
DRUG FOR FURTHER PROCESSING
5; 320
0078-1301_a1330bcd-681e-4b4f-9a1e-1317d1806346
amlodipine besylate and valsartan
HUMAN PRESCRIPTION DRUG
0078-1308
Novartis Pharmaceuticals Corporation
20070620
AMLODIPINE BESYLATE; VALSARTAN
DRUG FOR FURTHER PROCESSING
10; 320
0078-1308_a1330bcd-681e-4b4f-9a1e-1317d1806346
Clarithromycin
HUMAN PRESCRIPTION DRUG
0078-1315
Novartis Pharmaceuticals Corporation
20070904
CLARITHROMYCIN
DRUG FOR FURTHER PROCESSING
400
0078-1315_4a90b9c7-9ee0-4d1e-ab94-fe91417cd1e0
SECUKINUMAB
BULK INGREDIENT
0078-1322
Novartis Pharmaceuticals Corporation
20150121
SECUKINUMAB
BULK INGREDIENT
1
0078-1322_a868cfc4-515f-43b8-9234-e4264c19cdef
adalimumab-adaz
BULK INGREDIENT
0078-1329
Novartis Pharmaceuticals Corporation
20230701
ADALIMUMAB
BULK INGREDIENT
1
0078-1329_d6bfea79-27e9-4074-9cf2-2ebb50e1f4fe
omalizumab
BULK INGREDIENT
0078-1336
Novartis Pharmaceuticals Corporation
20030620
OMALIZUMAB
BULK INGREDIENT
1
0078-1336_e28e1c41-d327-4125-8750-efd08bbfb220
tocilizumab
BULK INGREDIENT
0078-1343
Novartis Pharmaceuticals Corporation
20100108
TOCILIZUMAB
BULK INGREDIENT
1
0078-1343_9bb4a19e-74d4-44c0-95ed-efb389ff24fd
denosumab
BULK INGREDIENT
0078-1350
Novartis Pharmaceuticals Corporation
20100605
DENOSUMAB
BULK INGREDIENT
1
0078-1350_45e01a38-665a-4d28-a590-21d9e4f45fde
ferumoxytol
BULK INGREDIENT
0078-1357
Novartis Pharmaceuticals Corporation
20210715
FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE
BULK INGREDIENT
1
0078-1357_5fc4e45a-914b-45e4-b6fa-a36e0d6b9466
alpelisib
BULK INGREDIENT
0078-1364
Novartis Pharmaceuticals Corporation
20220405
ALPELISIB
BULK INGREDIENT
1
0078-1364_a2f1a937-23af-4737-8a6e-b77269a28fe6
atorvastatin
BULK INGREDIENT
0078-1371
Novartis Pharmaceuticals Corporation
20130919
ATORVASTATIN CALCIUM TRIHYDRATE
BULK INGREDIENT
1
0078-1371_b0a6d76c-cacb-4499-a18a-c8353db652f2
lithium carbonate
BULK INGREDIENT
0078-1378
Novartis Pharmaceuticals Corporation
20090203
LITHIUM CARBONATE
BULK INGREDIENT
1
0078-1378_9d56234f-5220-4e34-8ef7-257bd2927ab2
mycophenolate mofetil
BULK INGREDIENT
0078-1385
Novartis Pharmaceuticals Corporation
20081015
MYCOPHENOLATE MOFETIL
BULK INGREDIENT
1
0078-1385_96df57a2-eb89-468e-9826-1ce28bb2dbd3
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3